ArticleAnnals of oncology : official journal of the European Society for Medical Oncology2013

Temsirolimus combined with sorafenib in hepatocellular carcinoma: a phase I dose-finding trial with pharmacokinetic and biomarker correlates.

R K Kelley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.